domingo, 17 de noviembre de 2024

Efficacy and safety of gefapixant in women with chronic cough and cough-induced stress urinary incontinence: a phase 3b, randomised, multicentre, double-blind, placebo-controlled trial

https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(24)00222-4/abstract?utm_campaign=infocusalerts-obgyn&utm_medium=email&dgcid=hubspot_email_infocusalerts-obgyn_feature&_hsenc=p2ANqtz-9UH8UmVBpItNEjQF0M7Qj1vIiO0KjqY3Uem17BoBsOC7MW8HlIG67pyyjTiVbJAv9ruukn4ccBTKbn952XF6oy36Sikw&_hsmi=334137311&utm_content=333916803&utm_source=hs_email

No hay comentarios:

Publicar un comentario